AI and Autonomy Canada launches public consultation on artificial intelligence transparency The consultation opened on Thursday and will remain available until Sept. 23 Joseph MortonJuly 24, 2026
Medical and Pharmaceutical Medtech investment firm NovoMed PARTNERS launches in California Its founders' oversaw CathWorks' US$585M takeover by Medtronic Rowan DunneJuly 24, 2026
Gold Scorpio Gold pulls C$10.8 million together to propel Nevada exploration The company is aiming to grow its gold resource from a defined 740,000 ounces to 2 million Rowan DunneJuly 24, 2026
Medical and Pharmaceutical Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test The CIZ1B test is meant to complement LDCT in detecting early-stage disease Rowan DunneJuly 23, 2026
Medical and Pharmaceutical CNS drug specialist Jupiter Neuro signs MDMA deal with PharmAla Biotech The pivotal agreement is valued at up to US$100 million Rowan DunneJuly 22, 2026
AI and Autonomy OpenAI bot autonomously hacks open-source AI leader Hugging Face This 'unprecedented cyber incident' showcases the evolving capabilities of AI technologies Rowan DunneJuly 22, 2026
AI and Autonomy Judge approves USD$1.5B Anthropic settlement over AI copyright dispute The lawsuit began in 2024 after several authors claimed Anthropic copied pirated versions of their books without permission Joseph MortonJuly 21, 2026
Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
AI and Autonomy Grayscale rebrands Bitcoin miners ETF to target booming AI infrastructure market The renamed ETF will target businesses that provide the technology supporting AI development Joseph MortonJuly 20, 2026
Medical and Pharmaceutical Common workout supplement creatine could strengthen cancer immunotherapy, UCLA study suggests Researchers began by studying dendritic cells taken from mice Joseph MortonJuly 20, 2026